Skip Nav Destination
Abstract 845: Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasis
Cancer Res (2011) 71 (8_Supplement): 845.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
A systematic review on the efficacy and safety of low molecular weight heparin as an anticancer therapeutic in preclinical animal models
- David Ripsman
- Dean A. Fergusson
- Joshua Montroy
- Rebecca C. Auer
- Johnny W. Huang
- Aditi Dobriyal
- Neil Wesch
- Marc Carrier
- Manoj M. Lalu
Thrombosis Research (2020) 195: 103.